Not yet recruiting
Efficacy and Safety of Tunlametinib Combination Therapy in the Treatment of Second-line and Above Metastatic Colorectal Cancer
NCT07714447
- Conditions
- BRAF, CRC (Colorectal Cancer), Colonic Diseases, +10 more
- Locations
-
- Sun Yat-sen University Guangzhou, Guangdong, China